| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |